The EuroBiotech Journal (Oct 2017)

Genetic testing for corneal dystrophies and other corneal Mendelian diseases

  • Abeshi Andi,
  • Fanelli Francesca,
  • Beccari Tommaso,
  • Dundar Munis,
  • Viola Francesco,
  • Colombo Leonardo,
  • Bertelli Matteo

DOI
https://doi.org/10.24190/ISSN2564-615X/2017/S1.13
Journal volume & issue
Vol. 1, no. s1
pp. 41 – 44

Abstract

Read online

We studied the scientific literature and disease guidelines in order to summarize the clinical utility of the genetic test for corneal dystrophies and other Mendelian corneal diseases (CDs). CDs are mostly inherited in an autosomal dominant manner (autosomal recessive inheritance is rare). The overall prevalence is currently unknown. CDs are caused by mutations in the AGBL1, CHST6, COL8A2, DCN, GSN, KRT12, KRT3, NLRP1, PAX6, PIKFYVE, PRDM5, SLC4A11, TACSTD2, TCF4, TGFBI, UBIAD1, VSX1, ZEB1, and ZNF469 genes. Clinical diagnosis is based on clinical findings, ophthalmological examination, confocal microscopy and slit-lamp biomicroscopy. The genetic test is useful for confirming diagnosis and for differential diagnosis, couple risk assessment and access to clinical trials.